Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients
Public ClinicalTrials.gov record NCT02106962. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients
Study identification
- NCT ID
- NCT02106962
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- California Institute of Renal Research
- Other
- Enrollment
- 17 participants
Conditions and interventions
Conditions
Interventions
- Topical Tranexamic Acid 5% with bacitracin Drug
- Topical Tranexamic Acid 25% with bacitracin Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2014
- Primary completion
- Jul 31, 2014
- Completion
- Jul 31, 2014
- Last update posted
- Sep 24, 2017
2014
United States locations
- U.S. sites
- 3
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Fresenius Medical Care - Kearny Mesa | San Diego | California | 92111 | — |
| California Insitute of Renal Research | San Diego | California | 92123 | — |
| Fresenious Medical Care - Rancho | San Diego | California | 92127 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02106962, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 24, 2017 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02106962 live on ClinicalTrials.gov.